“…This lack of emphasis is somewhat surprising given that MHIs in elite athletes have attracted considerable attention in recent years (Gouttebarge, Backx, Aoki, & Kerkhoffs, 2015;Reardon & Factor, 2010;Rice et al, 2016;Schaal et al, 2011) and that depression, in particular, is a common societal concern that affects both the general and sporting population (Doherty, Hannigan, & Campbell, 2016;Lebrun, MacNamara, Rodgers, & Collins, 2018;WHO, 2018). Although the prevalence of depression amongst elite athletes remains unclear (Beable, Fulcher, Lee, & Hamilton, 2017;Reardon & Factor, 2010;Rice et al, 2016) and is often underestimated (Hammond, Gialloreto, Kubas, & Davis, 2013), the occurrence of depressive symptoms is currently thought to be comparable to (Beable et al, 2017;Gulliver, Griffiths, Mackinnon, Batterham, & Stanimirovic, 2015), or greater (Roberts, Faull, & Tod, 2016) than the general population.…”